GlaxoSmithKline Plc ADR (GSK)



GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. Its principal pharmaceutical products include medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, oncology and emesis, dermatalogicals and vaccines. The Company's segments include Pharmaceuticals and Consumer Healthcare.

Data as of 2020-07-04
Market Cap103.406 Billion Shares Outstanding2.509 Billion Avg 30-day Volume2.816 Million
P/E Ratio14.4 Dividend Yield4.581 EPS2
Price/Sales0.038 Price cash flow ratio10.0 Price free cash flow ratio30.1
Book Value6.42 Price to Tangible Book-2.82 Alpha-0.0
Short Interest Ratio2.52 % Short Interest to Float0.3 R-squared0.362119
BETA0.702967 52-week High/Low48.25 / 31.43 Stddev0.049747
View SEC Filings from GSK instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 15 7 (0.46%)
13F Filers holding this stock: 781 118 (7.73%)
Aggregate 13F shares on 03/31/2020: 311.782 Million 121.705 Million
Aggregate 13F shares on 12/31/2019: 287.399 Million 103.149 Million
Percent change: 8.48% 17.99%
Funds creating new positions: 70 18
Funds Adding to an existing position: 254 44
Funds closing out their position: 131 27
Funds reducing their position: 328 41
1 hedge funds as identified by through public filings.

Funds Holding GSK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GSK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments